Biohaven real-world study highlights increased healthcare utilization among americans with episodic migraine having higher levels of migraine-related disability

More than 25% of patients reported being severely or very severely impacted by their migraine attacks study showed higher levels of migraine-related disability were associated with increased hcru costs in primary care and specialty settings among adults with episodic migraine data suggests that assessment of disability in people with migraine may support prescribing of cost-effective interventions, particularly among those with severe disability new haven, conn., april 14, 2022 /prnewswire/ -- biohaven pharmaceutical holding company ltd.
BHVN Ratings Summary
BHVN Quant Ranking